search
Back to results

Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease (PLHYMANEDE)

Primary Purpose

Cognitive Impairment, Alzheimer Disease

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Relational care
Hypno-analgesia
Sponsored by
University Hospital, Montpellier
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Cognitive Impairment focused on measuring neuro degenerative diseases, Alzheimer's disease, lumbar puncture, CSF, hypno analgesia, no drug care, pain, anxiety, counseling

Eligibility Criteria

50 Years - 90 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria:

  • Patient presenting clinical symptoms that may reflect Alzheimer's disease according to the criteria of NIA 2011, with either an isolated hippocampal episodic deficit or associated with dys-executive, phasic or praxic disorders of memory disorder, of insidious progressive evolution with a documented cognitive decline
  • Global cognitive score with Mini Mental State MMS between 22 and 27;
  • Age between 50 and 90 years ;
  • Written and informed consent for this study signed by the patient

Exclusion criteria:

  • Refusal to have a LP procedure in the diagnosis process ;
  • Refusal to participate in a session of hypno-analgesia;
  • Refusal to be filmed during the LP ;
  • Patient having already had a session of hypno-analgesia for other diagnostic assessments;
  • Patient that done yoga or quite different technique of relaxation ;
  • Socio-educational level not allowing the understanding of the neuropsychological tests;
  • Not able to follow the majority of the aspects of the study without accompanying ;
  • Refusal to sign the written and informed consent ;
  • Patient deprived of freedom by court or administrative order

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Other

    Other

    Arm Label

    Standard Care

    Hypnosis

    Arm Description

    Relational care used to help the patient by reducing the fear and anxiety

    Hypno-analgesia is used to help the patient by reducing the fear and anxiety

    Outcomes

    Primary Outcome Measures

    Algoplus score of pain during the LP procedure
    Evaluation of the pain during the Lumbar Punction procedure using the ALGOPLUS (Scale of behavioral evaluation of the pain on 30 points, 30 points being the worst pain) Scale assessment on the patients of each group

    Secondary Outcome Measures

    Rate of failure of the Lumbar Ponction
    This outcome is defined by the incapacity to perform the Lumbar Punction or by the incapacity to collect 12 ml of CSF (cererbrospinal fluid) therefore is defined by the number of the Lumbar Punction aborted
    Evaluation of the anxiety
    Assessed by an self-completed questionnaire STAI (State-Trait Anxiety Inventory, STAI-Y-A) done before and after the Lumbar Punction and oriented on the anxiety during the LP
    Evaluation of the pain
    assessed by the Pain monitorTM . The threshold is fixed in 0.2 pic/seconds over whom it is considered that pain is present
    Evaluation of the pain by the patient
    assessed by the scales EVA (Visual analog scale)
    Evaluation of the pain by the patient
    assessed by the scales EVS (Simple Verbal scale)

    Full Information

    First Posted
    November 16, 2017
    Last Updated
    November 20, 2020
    Sponsor
    University Hospital, Montpellier
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03352024
    Brief Title
    Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease
    Acronym
    PLHYMANEDE
    Official Title
    Impact of Hypno-analgesia, Non-drugs Technique of Care, on Pain That May Inverve During a Lumbar Puncture for Diagnosis of Patient With Mild to Moderate Alzheimer's Dementia.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2017
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    internal organizational problem and dysfunction of study material
    Study Start Date
    January 2018 (Anticipated)
    Primary Completion Date
    November 2020 (Anticipated)
    Study Completion Date
    November 13, 2020 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University Hospital, Montpellier

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    One of the missions of the Memory of Resources and Research Center (CMRR) is to establish a diagnosis of expertise in patients with amestic, language or behavioral cognitive complaint. Thanks to the dosage of specific biomarkers in the cererbrospinal fluid (CSF), it is currently possible to determine the underlying process of the disease in vivo by assess the pathological amyloid and Tau profile. To obtain these very sensitive and specific biomarkers, clinicians need to perform lumbar puncture (LP). . This exam is easy and reproducible but the gesture image remained negative despite some advances in the materials and care.. Within the Department of Neurology of Montpellier, the recommendations of the Haute Autorité de Santé (HAS) about pain management in adults are applied. A transdermal device of lidocaine-pilocaine (type EMLA) is applied 120 minutes before the LP . In addition, an equimolar oxygen-nitrous oxide (MEOPA) mixture could be added. Then, patients benefit from a helping relationship before and during the gesture dedicated to reduce anxiety. Until recently, non-medicinal techniques (relaxation, hypnosis ...) were not recommendedin cases of major anxiety or analgesia deemed insufficient. Many studies have shown the efficiency of hypnoalgia in invasive gestures in young children. The University Hospital of Montpellier have developed training about hypnoanalgesia and have been implemented for patients with neurological disorders in our unit. A reduction and even a suppression of pain and a limitation of the apprehension of the gesture have been judged satisfactory both for the patient, the practionner and the nurse practicing regularly the LP. However, this evalusation remained subjective and clinically-based. Thus, it seems relevantto analyse the effect of this technic in order th test the following hypothesis: hypno-analgesia (non-medicinal technique of care) associated with EMLA patch is more effective than the helping relationship associated with EMLA patch to reduce the pain that may inverse during the LP for diagnosis in patient with mild to moderate stage of Alzheimer's disease.
    Detailed Description
    The main objective was to assess whether the use of hypnoanalgesia technic during the LP procedure comparing to commun procedure reduce the pain of the patient evaluated by the hetero-evaluation ALGOPLUS scale. Secondary objectives were to evaluate the differences between the hypno-analgesia and the helping relationship on: pain assessed by the Simple Verbal Scale (EVS); pain assessed by the Visual Analog Scale (EVA); pain and stress measured by conductance analysis; the anxiety score assessed by a STAI self-assessment questionnaire (State-Trait Anxiety Inventory, STAI-Y); the rate of failure during the LP procedure. Methodology : A monocentric randomized controlled, open-label (with an evaluation of the blind randomization of the randomization arm) with two parallel arms: the arm named "hypno-analgesia + EMLA patch" = cutaneous anesthesia associated with hypno-analgesia. the arm called "helping relationship + EMLA patch" = cutaneous anesthesia associated with a helping relationship The estimated number of patients was 100. Analysis of the primary outcome measure: The score of the ALGOPLUS scale will compared between the two groups of patients using the Chi2 test after checking the validity conditions of the test. The project will last 36 months and the duration of the inclusions 24 months. The LP will be carried out during one day of hospitalization as part of the diagnosis assessments. No specific follow-up is scheduled.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Cognitive Impairment, Alzheimer Disease
    Keywords
    neuro degenerative diseases, Alzheimer's disease, lumbar puncture, CSF, hypno analgesia, no drug care, pain, anxiety, counseling

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Outcomes Assessor
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Standard Care
    Arm Type
    Other
    Arm Description
    Relational care used to help the patient by reducing the fear and anxiety
    Arm Title
    Hypnosis
    Arm Type
    Other
    Arm Description
    Hypno-analgesia is used to help the patient by reducing the fear and anxiety
    Intervention Type
    Other
    Intervention Name(s)
    Relational care
    Intervention Description
    Relational care is combined with a cutaneous anesthesia (Transcutaneous device(plan) of lidocaïne-pilocaïne (EMLA®))
    Intervention Type
    Other
    Intervention Name(s)
    Hypno-analgesia
    Intervention Description
    Hypno-analgesia is combined with a cutaneous anesthesia (Transcutaneous device(plan) of lidocaïne-pilocaïne (EMLA®))
    Primary Outcome Measure Information:
    Title
    Algoplus score of pain during the LP procedure
    Description
    Evaluation of the pain during the Lumbar Punction procedure using the ALGOPLUS (Scale of behavioral evaluation of the pain on 30 points, 30 points being the worst pain) Scale assessment on the patients of each group
    Time Frame
    1 day
    Secondary Outcome Measure Information:
    Title
    Rate of failure of the Lumbar Ponction
    Description
    This outcome is defined by the incapacity to perform the Lumbar Punction or by the incapacity to collect 12 ml of CSF (cererbrospinal fluid) therefore is defined by the number of the Lumbar Punction aborted
    Time Frame
    1 day
    Title
    Evaluation of the anxiety
    Description
    Assessed by an self-completed questionnaire STAI (State-Trait Anxiety Inventory, STAI-Y-A) done before and after the Lumbar Punction and oriented on the anxiety during the LP
    Time Frame
    1 day
    Title
    Evaluation of the pain
    Description
    assessed by the Pain monitorTM . The threshold is fixed in 0.2 pic/seconds over whom it is considered that pain is present
    Time Frame
    1 day
    Title
    Evaluation of the pain by the patient
    Description
    assessed by the scales EVA (Visual analog scale)
    Time Frame
    1 day
    Title
    Evaluation of the pain by the patient
    Description
    assessed by the scales EVS (Simple Verbal scale)
    Time Frame
    1 day

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    50 Years
    Maximum Age & Unit of Time
    90 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion criteria: Patient presenting clinical symptoms that may reflect Alzheimer's disease according to the criteria of NIA 2011, with either an isolated hippocampal episodic deficit or associated with dys-executive, phasic or praxic disorders of memory disorder, of insidious progressive evolution with a documented cognitive decline Global cognitive score with Mini Mental State MMS between 22 and 27; Age between 50 and 90 years ; Written and informed consent for this study signed by the patient Exclusion criteria: Refusal to have a LP procedure in the diagnosis process ; Refusal to participate in a session of hypno-analgesia; Refusal to be filmed during the LP ; Patient having already had a session of hypno-analgesia for other diagnostic assessments; Patient that done yoga or quite different technique of relaxation ; Socio-educational level not allowing the understanding of the neuropsychological tests; Not able to follow the majority of the aspects of the study without accompanying ; Refusal to sign the written and informed consent ; Patient deprived of freedom by court or administrative order
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Audrey GABELLE, MD, PhD
    Organizational Affiliation
    CHU de Montpellier
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Impact of Hypno-analgesia on Pain During a Lumbar Puncture for Diagnosis of Alzheimer's Disease

    We'll reach out to this number within 24 hrs